Sign up to save your podcasts
Or
Share #21 - Julie O'Shaughnessy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#21 - Julie O'Shaughnessy
▶️Hosts: Elizabeth Rodziewicz, Sura Hadi, Jeff Nagle, and Mike Ouren
🚀 The best ideas don’t always win—execution does.In the final episode of our Blueprints to Breakthroughs series, we sit down with Julie O’Shaughnessy, COO of Vivodyne, to uncover why biotech operations are the secret weapon behind scaling scientific discoveries into real-world breakthroughs.
🔹 Why do biotech startups struggle to transition from R&D to commercialization?
🔹 How does operational strategy determine whether an idea succeeds or fails?
🔹 What’s the key to building scalable, resilient biotech companies?
Julie brings deep expertise from her time at Barclays, Amazon, Resilience, and now Vivodyne, sharing hard-won lessons on leadership, scaling biotech, and how operational inefficiencies can kill innovation.
📅 Watch now to learn why operations can make or break a biotech startup!
📢 Next up: More exciting guests coming soon - follow to stay updated!
🔔 Subscribe & follow for more insights on biotech, automation, and scaling innovation. 🎧 linktr.ee/helicalbrew
💬 What do you think is the biggest challenge in scaling biotech? Drop your thoughts in the comments!
🔁 Like, comment & share with biotech leaders, startup founders, and innovation strategists!
📌 TIMESTAMPS – NAVIGATE THE EPISODE
00:00 Intro & Welcome to Episode 21
02:00 Julie’s Unconventional Path to Biotech Leadership
07:30 The Role of Operations in Biotech Scaling
13:00 Why Startups Fail: The Missing Operational Foundation
18:45 Compliance, Regulatory Challenges & The Path to Commercialization
23:00 Founder Mode vs. True Alignment in Scaling Startups
30:00 Lessons from Amazon & Large Corporations on Scaling
36:30 How Operational Inefficiencies Kill Innovation
42:00 Digital Tools & Automation in Biotech Operations
50:00 The Future of Biotech & Leadership Advice
58:00 Vivodyne’s Vision & What’s Next
1:05:00 Picks of the Week & Wrap-Up
📌 NEED QUICK HIGHLIGHTS? WATCH OUR SHORTS:
▶️https://youtube.com/shorts/bp1UGQxX6lw?feature=share
▶️ https://youtube.com/shorts/Pa1EuNEvpno?feature=share
▶️ https://youtube.com/shorts/-EqwdBEBltE?feature=share
#HelicalBrew #Biotech #ScalingInnovation #BlueprintsToBreakthroughs #Startups #OperationsMatter #BiotechOperations #ScientificInnovation #FutureOfScience #BiotechStartups #Leadership #TechForScience
View all episodes
By Sura Hadi | Mike Ouren | Elizabeth Rodziewicz▶️Hosts: Elizabeth Rodziewicz, Sura Hadi, Jeff Nagle, and Mike Ouren
🚀 The best ideas don’t always win—execution does.In the final episode of our Blueprints to Breakthroughs series, we sit down with Julie O’Shaughnessy, COO of Vivodyne, to uncover why biotech operations are the secret weapon behind scaling scientific discoveries into real-world breakthroughs.
🔹 Why do biotech startups struggle to transition from R&D to commercialization?
🔹 How does operational strategy determine whether an idea succeeds or fails?
🔹 What’s the key to building scalable, resilient biotech companies?
Julie brings deep expertise from her time at Barclays, Amazon, Resilience, and now Vivodyne, sharing hard-won lessons on leadership, scaling biotech, and how operational inefficiencies can kill innovation.
📅 Watch now to learn why operations can make or break a biotech startup!
📢 Next up: More exciting guests coming soon - follow to stay updated!
🔔 Subscribe & follow for more insights on biotech, automation, and scaling innovation. 🎧 linktr.ee/helicalbrew
💬 What do you think is the biggest challenge in scaling biotech? Drop your thoughts in the comments!
🔁 Like, comment & share with biotech leaders, startup founders, and innovation strategists!
📌 TIMESTAMPS – NAVIGATE THE EPISODE
00:00 Intro & Welcome to Episode 21
02:00 Julie’s Unconventional Path to Biotech Leadership
07:30 The Role of Operations in Biotech Scaling
13:00 Why Startups Fail: The Missing Operational Foundation
18:45 Compliance, Regulatory Challenges & The Path to Commercialization
23:00 Founder Mode vs. True Alignment in Scaling Startups
30:00 Lessons from Amazon & Large Corporations on Scaling
36:30 How Operational Inefficiencies Kill Innovation
42:00 Digital Tools & Automation in Biotech Operations
50:00 The Future of Biotech & Leadership Advice
58:00 Vivodyne’s Vision & What’s Next
1:05:00 Picks of the Week & Wrap-Up
📌 NEED QUICK HIGHLIGHTS? WATCH OUR SHORTS:
▶️https://youtube.com/shorts/bp1UGQxX6lw?feature=share
▶️ https://youtube.com/shorts/Pa1EuNEvpno?feature=share
▶️ https://youtube.com/shorts/-EqwdBEBltE?feature=share
#HelicalBrew #Biotech #ScalingInnovation #BlueprintsToBreakthroughs #Startups #OperationsMatter #BiotechOperations #ScientificInnovation #FutureOfScience #BiotechStartups #Leadership #TechForScience